** Shares in Orion ORNBV.HE rise 5.9% after the Finnish
drugmaker revised its FY operating profit outlook upwards on the
back of its Q1 results
** The company said in a statement its operating profit for
2024 is estimated to be in range of EUR 280-310 million from its
previous EUR 270-310 million, mainly driven by strong Q1
performance, key product growth, and R&D progress
** "As Orion's profitability has been under pressure last
year, the upgraded guidance may have relieved some investor
concerns regarding 2024 profitability," says Inderes analyst
Antii Siltanen
** Shares are on track for a best day since July 2022
($1 = 0.9321 euros)
(Reporting by Jesus Calero)
((Jesus.calero@thomsonreuters.com))